Cargando…
Vaccination of biliary tract cancer patients with four peptides derived from cancer-testis antigens
In the context of a Phase I clinical trial, the long-term vaccination of advanced biliary tract cancer patients with peptides derived from four distinct cancer-testis antigens resulted in remarkable disease stability and in the elicitation of antigen-specific T-cell responses.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Landes Bioscience
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782136/ https://www.ncbi.nlm.nih.gov/pubmed/24073370 http://dx.doi.org/10.4161/onci.24882 |
| _version_ | 1782285519979282432 |
|---|---|
| author | Aruga, Atsushi |
| author_facet | Aruga, Atsushi |
| author_sort | Aruga, Atsushi |
| collection | PubMed |
| description | In the context of a Phase I clinical trial, the long-term vaccination of advanced biliary tract cancer patients with peptides derived from four distinct cancer-testis antigens resulted in remarkable disease stability and in the elicitation of antigen-specific T-cell responses. |
| format | Online Article Text |
| id | pubmed-3782136 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | Landes Bioscience |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-37821362013-09-26 Vaccination of biliary tract cancer patients with four peptides derived from cancer-testis antigens Aruga, Atsushi Oncoimmunology Author's View In the context of a Phase I clinical trial, the long-term vaccination of advanced biliary tract cancer patients with peptides derived from four distinct cancer-testis antigens resulted in remarkable disease stability and in the elicitation of antigen-specific T-cell responses. Landes Bioscience 2013-07-01 2013-05-07 /pmc/articles/PMC3782136/ /pubmed/24073370 http://dx.doi.org/10.4161/onci.24882 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
| spellingShingle | Author's View Aruga, Atsushi Vaccination of biliary tract cancer patients with four peptides derived from cancer-testis antigens |
| title | Vaccination of biliary tract cancer patients with four peptides derived from cancer-testis antigens |
| title_full | Vaccination of biliary tract cancer patients with four peptides derived from cancer-testis antigens |
| title_fullStr | Vaccination of biliary tract cancer patients with four peptides derived from cancer-testis antigens |
| title_full_unstemmed | Vaccination of biliary tract cancer patients with four peptides derived from cancer-testis antigens |
| title_short | Vaccination of biliary tract cancer patients with four peptides derived from cancer-testis antigens |
| title_sort | vaccination of biliary tract cancer patients with four peptides derived from cancer-testis antigens |
| topic | Author's View |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782136/ https://www.ncbi.nlm.nih.gov/pubmed/24073370 http://dx.doi.org/10.4161/onci.24882 |
| work_keys_str_mv | AT arugaatsushi vaccinationofbiliarytractcancerpatientswithfourpeptidesderivedfromcancertestisantigens |